Sponsor overview

Shanghai Miracogen .

Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.

Back to report

Summary

Signal counts

Assets tracked: 2

Watchlist assets: 2

Registry stop assets: 0

Evidence links

Public sources

https://clinicaltrials.gov/study/NCT05141786 | https://clinicaltrials.gov/study/NCT05141747 | https://clinicaltrials.gov/study/NCT04839510 | https://clinicaltrials.gov/study/NCT04838964

Assets

Linked programs

MRG002: Timeline Staleness Signal (4/5)
MRG003: Timeline Staleness Signal (4/5)